GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » Short Percentage of Float

Ceapro (TSXV:CZO) Short Percentage of Float


View and export this data going back to 1992. Start your Free Trial

What is Ceapro Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Ceapro's Short Percentage of Float

For the Biotechnology subindustry, Ceapro's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ceapro's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ceapro's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Ceapro's Short Percentage of Float falls into.


Ceapro (TSXV:CZO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » Short Percentage of Float
Comparable Companies
XCNQ:PHRM XCNQ:TELI XCNQ:MDMA TSXV:CYTO TSXV:SBM TSXV:KNE TSX:RVX TSX:ATE TSX:APS XCNQ:DOSE OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
CRPOF:USA
Address
7824-51 Avenue NW, Edmonton, AB, CAN, T6E 6W2
Website
https://www.ceapro.com
Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

Ceapro (TSXV:CZO) Headlines

No Headlines